GlassScriptPhysician profile
Suzanne B Bryant
NPI 1336434356
$18,968.66
in general payments reported to CMS, 2019-2025
5 companies · $6,656 in 2025
The $6,656 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,875 · 2023: $2,804 · 2024: $6,633 · 2025: $6,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,771 · Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,200.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,770.96 |
| Food and Beverage | $122.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $13,200.00 | 2024-2025 | Bovine Collagen |
| Organon LLC | $5,696.41 | 2022-2025 | Nexplanon, Jada System |
| Innocoll Pharmaceuticals Limited | $41.30 | 2022 | |
| Hologic Sales and Service, LLC | $16.55 | 2025 | Myosure Tissue Removal Device |
| Ipsen Biopharmaceuticals, INC | $14.40 | 2023 | Bylvay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.